References
- Micali G, Lacarrubba F, Dinotta F, Massimino D, Nasca MR. Treating skin cancer with topical cream. Expert Opin Pharmacother. 2010;11:1515–1527.
- Drehs MM, Cook-Bolden F, Tanzi EL, Weinberg JM. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Dermatol Surg. 2002;28:427–429.
- Berman B, Sullivan T, De Araujo T, Nadji M. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol. 2003;66:59–61.
- Chen TM, Rosen T, Orengo I. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatol Surg. 2002;28:344–346.
- Shumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol. 2004;140:1286–1287.
- Micali M, Nasca MR, Musumeci ML. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. Int J Tissue React. 2005;27:111–114.
- Malhotra AK, Bansal A, Mridha AR, Khaitan BK, Verma KK. Superficial basal cell carcinoma on face treated with 5% imiquimod cream. Indian J Dermatol Venereol Leprol. 2006;72:373–375.
- Mehta V, Balachandran C. Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream. Indian J Dermatol. 2008;53:140–141.
- Schiessl C, Wolber C, Tauber M, Offner F, Strohal R. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drugs Dermatol. 2007;6:507–513.
- Shulstad RM. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Dermatol Nurs. 2009;21:86–87.
- Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50:722–733.
- Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol. 2002;47:390–398.
- Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005;152:939–947.
- Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol. 2002;147:1227–1236.
- Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Möhrle M, A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol. 2007;57:616–621.
- Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. Australasian Multicentre Trial Group. J Am Acad Dermatol. 2001;44:807–813.